Human TDP-43 overexpression in zebrafish motor neurons triggers MND-like phenotypes through gain-of-function mechanism
Alison L. HoganiD, Madison A. KaneiD, Patrick Chiu, G. RichteriD, Cindy MaureliD, Sharlynn WuiD, Natalie M. SchereriD, Emily K. DoniD, Albert LeeiD, Ian P. BlairiD, Roger S. ChungiD, Marco MorschiD
Abstract
Dysregulation of the TAR DNA-binding protein 43 (TDP-43), including intraneuronal cytoplasmic mislocalisation and aggregation is a feature of multiple neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal lobar dementia (FTLD), limbic-predominant age-related TDP-43 encephalopathy (LATE) and alzheimers disease (AD). Unravelling the causes and functional consequences of TDP-43 dysregulation is paramount to understanding disease mechanisms as well as identifying effective therapeutic targets. Here we present a comprehensive in vivo characterisation of three stable transgenic zebrafish models that express human TDP-43 variants in motor neurons. We demonstrate that overexpression of predominantly nuclear wildtype TDP-43, cytoplasm-targeted TDP-43, and an ALS-linked variant (G294V) each induce toxic gain-of-function effects, leading to impaired motor function, motor neuron loss, and muscle atrophy. Importantly, these models reveal distinct phenotypes, with the ALS-linked mutant exhibiting axonal transport deficits and neuromuscular junction disruption, while cytoplasmic mislocalised TDP-43 heightened susceptibility to oxidative stress. Two FDA-approved drugs used to treat ALS, edaravone and riluzole, were examined in these models and revealed that edaravone, but not riluzole, was effective in rescuing motor deficits associated with cytoplasmic TDP-43 expression and, to a lesser extent, mutant TDP-43G294V. Collectively, these findings reveal distinct pathological consequences of TDP-43 dysregulation, providing neuron-centric mechanistic insights, and establish the humanised TDP-43 zebrafish as an efficient system for preclinical therapeutic testing. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=147 SRC="FIGDIR/small/663393v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@18c4a50org.highwire.dtl.DTLVardef@162df7forg.highwire.dtl.DTLVardef@3f2848org.highwire.dtl.DTLVardef@6d9439_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 3.04
- Field percentile
- top 8%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice
Chunxing Yang, Tao Qiao, … Zuoshang Xu·PLoS ONEPeer-reviewed·Feb 3, 2022
- A Human Neuronal Cell Model of Endogenous TDP-43 A315T Reveals Altered Protein Dynamics and Disease-Relevant Cellular Dysfunction
M.E. Cicardi, Sara Antonini, … Davide Trotti·bioRxiv·Sep 5, 2026
- Dysregulated TDP-43 proteostasis perturbs excitability of spinal motor neurons during brainstem-mediated fictive locomotion in zebrafish
Kazuhide Asakawa, Hiroshi Handa, Koichi Kawakami·Development Growth & DifferentiationPeer-reviewed·Jul 15, 2023
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
Juan Miguel Godoy-Corchuelo, Zeinab Ali, … Silvia Corrochano·Neurobiology of DiseasePeer-reviewed·Feb 15, 2024
- Restoring multiple TDP-43 cryptic targets, but not solely Unc13a, rescues motor neuron disease
Aswathy Peethambaran Mallika, Meghraj Singh Baghel, … Philip C. Wong·bioRxiv·Sep 18, 2026
- Corticospinal propagation of full-length TDP-43 toxicity drives brain-to-muscle pathology
Jacopo Marongiu, V. Crippa, … Anna Rosa Carta·bioRxiv·Mar 30, 2026